News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,658 Results
Type
Article (41722)
Company Profile (473)
Press Release (661463)
Section
Business (208445)
Career Advice (2010)
Deals (35954)
Drug Delivery (97)
Drug Development (83368)
Employer Resources (169)
FDA (16343)
Job Trends (15049)
News (352210)
Policy (32994)
Tag
Academia (2619)
Alliances (50710)
Alzheimer's disease (1307)
Approvals (16294)
Artificial intelligence (155)
Bankruptcy (361)
Best Places to Work (11783)
Biotechnology (355)
Breast cancer (195)
Cancer (1416)
Cardiovascular disease (117)
Career advice (1677)
Cell therapy (302)
Clinical research (66481)
Collaboration (511)
Compensation (266)
COVID-19 (2601)
C-suite (115)
Data (1418)
Diabetes (180)
Diagnostics (6229)
Earnings (86122)
Employer resources (147)
Events (113499)
Executive appointments (405)
FDA (17045)
Funding (452)
Gene therapy (213)
GLP-1 (635)
Government (4418)
Healthcare (19025)
Infectious disease (2694)
Inflammatory bowel disease (118)
Interviews (309)
IPO (16623)
Job creations (3696)
Job search strategy (1430)
Layoffs (445)
Legal (7937)
Lung cancer (203)
Manufacturing (215)
Medical device (13362)
Medtech (13367)
Mergers & acquisitions (19489)
Metabolic disorders (486)
Neuroscience (1649)
NextGen Class of 2024 (6738)
Non-profit (4537)
Northern California (1725)
Obesity (277)
Opinion (202)
Parkinson's disease (102)
Patents (121)
People (57829)
Phase I (20862)
Phase II (29344)
Phase III (21695)
Pipeline (523)
Postmarket research (2598)
Preclinical (8937)
Radiopharmaceuticals (252)
Rare diseases (283)
Real estate (5999)
Regulatory (22127)
Research institute (2405)
Resumes & cover letters (351)
Southern California (1501)
Startups (3747)
United States (15711)
Vaccines (581)
Weight loss (199)
Date
Today (91)
Last 7 days (573)
Last 30 days (2461)
Last 365 days (36392)
2024 (36230)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54923)
2019 (47419)
2018 (35697)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32186)
2013 (27111)
2012 (29221)
2011 (29863)
2010 (27992)
Location
Africa (731)
Arizona (204)
Asia (38676)
Australia (6432)
California (3943)
Canada (1467)
China (313)
Colorado (177)
Connecticut (189)
Europe (84349)
Florida (542)
Georgia (136)
Illinois (401)
Indiana (228)
Maryland (651)
Massachusetts (3109)
Michigan (177)
Minnesota (298)
New Jersey (1132)
New York (1109)
North Carolina (803)
Northern California (1725)
Ohio (148)
Pennsylvania (940)
South America (1106)
Southern California (1501)
Texas (571)
Utah (110)
Washington State (415)
703,658 Results for "pliant therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pliant Therapeutics to Participate in Upcoming Investor Events
November 21, 2024
·
2 min read
Business
Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors
Pliant Therapeutics, Inc., a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, announced the appointment of Steve Krognes to its Board of Directors.
June 13, 2024
·
5 min read
Press Releases
Pliant Therapeutics to Participate in the Stifel Healthcare Conference
November 6, 2024
·
1 min read
Biotech Bay
Pliant Therapeutics to Participate in Upcoming Investor Events - May 1 2024
Pliant Therapeutics, Inc. today announced participation in the following May investor events.
May 1, 2024
·
2 min read
Press Releases
Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024
November 19, 2024
·
4 min read
Biotech Bay
Pliant Therapeutics to Participate in Upcoming April 2024 Investor Events
Pliant Therapeutics, Inc., a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, announced participation in the following April investor events.
April 2, 2024
·
2 min read
Business
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage clinical biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today provided a corporate update and reported first quarter 2024 financial results.
May 6, 2024
·
10 min read
Press Releases
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
November 8, 2024
·
8 min read
Biotech Bay
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 12, 2024
Pliant Therapeutics, Inc., announced that on June 10, 2024, it granted stock options to purchase an aggregate of 120,000 shares of common stock upon vesting to Chohee Yun, M.D., the Company’s newly appointed Senior Vice President of Clinical Development as a material inducement to her employment.
June 12, 2024
·
2 min read
Biotech Bay
Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™
Pliant Therapeutics, Inc. announced two poster presentations, including a late-breaker, at the upcoming European Association for the Study of the Liver International Liver Congress™ taking place in Milan, Italy from June 5-8, 2024.
May 7, 2024
·
2 min read
1 of 70,366
Next
